Literature DB >> 18626238

Is anaerobic blood culture necessary? If so, who needs it?

Kentaro Iwata1, Miwa Takahashi.   

Abstract

BACKGROUND: The role of anaerobic blood cultures is not validated, although they are drawn routinely.
METHODS: We performed a retrospective chart review at a private hospital in Japan for patients admitted between July 1, 2004 to June 30, 2005 to determine patient characteristics resulting in anaerobic blood culture.
RESULTS: During the study period, 17,775 blood culture bottles were sent for the analysis, and 2132 bottles (12.0%) were positive for microbial growth. Bacteria were grown from 958 anaerobic bottles (44.7%), and 719 (33.7%) of those were judged to represent real infections, which accounted for 410 cases of bacteremia. Only 47 cases (11.5%) were detected by anaerobic cultures alone. Among those 47, obligate anaerobes represented 12 cases. Clinical evaluation could have predicted 7 of 12 cases of obligate anaerobic bacteremia. In the remaining 5 cases, the source of bacteremia was unclear. There were 2.7 cases of anaerobic bacteremia per 1000 blood cultures. The mortality attributable to anaerobic bacteremia was 50%. Among bacteremic cases not caused by obligate anaerobes yet diagnosed solely by anaerobic bottles, either the standard 2 sets of blood were not taken or their clinical outcomes were favorable.
CONCLUSION: Anaerobic blood culture can be avoided in most cases. Anaerobic blood culture may be most helpful when (1) bacteremia because of obligate anaerobes is clinically suspected, (2) patients are severely immunocompromised, and (3) source of bacteremia is not identified by clinical evaluation.

Entities:  

Mesh:

Year:  2008        PMID: 18626238     DOI: 10.1097/MAJ.0b013e31815dca24

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

Review 1.  Diagnosis of Bloodstream Infections in Children.

Authors:  Jennifer Dien Bard; Erin McElvania TeKippe
Journal:  J Clin Microbiol       Date:  2016-01-27       Impact factor: 5.948

2.  Evaluation of an intervention to improve blood culture practices: a cluster randomised trial.

Authors:  P Pavese; M Maillet; V Vitrat-Hincky; C Recule; J-P Vittoz; A Guyomard; A Seigneurin; P François
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-02       Impact factor: 3.267

3.  The Addition of Anaerobic Blood Cultures for Pediatric Patients with Concerns for Bloodstream Infections: Prevalence and Time to Positive Cultures.

Authors:  Jennifer Dien Bard; Todd P Chang; Rebecca Yee; Keya Manshadi; Nhan Lichtenfeld; Hee Jae Choi; Ara Festekjian
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

4.  Five-year retrospective epidemiological survey of anaerobic bacteraemia in a university hospital and rewiew of the literature.

Authors:  E Urbán
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-06-13

5.  Routine Use of Anaerobic Blood Culture Bottles for Specimens Collected from Adults and Children Enhances Microorganism Recovery and Improves Time to Positivity.

Authors:  Eric M Ransom; Carey-Ann D Burnham
Journal:  J Clin Microbiol       Date:  2022-08-30       Impact factor: 11.677

6.  Do Positive Anaerobic Culture Results Affect Physicians' Clinical Management Decisions?

Authors:  Tanaya Bhowmick; Tilly A Varughese; Schweta Arakali; Susan E Boruchoff
Journal:  Open Forum Infect Dis       Date:  2017-01-19       Impact factor: 3.835

7.  Utility of anaerobic bottles for the diagnosis of bloodstream infections.

Authors:  M Lafaurie; E d'Anglejan; J L Donay; D Glotz; E Sarfati; M Mimoun; M Legrand; E Oksenhendler; M Bagot; S Valade; B Bercot; J M Molina
Journal:  BMC Infect Dis       Date:  2020-02-14       Impact factor: 3.090

8.  Vaginal colonization with antimicrobial-resistant bacteria among women in labor in central Uganda: prevalence and associated factors.

Authors:  Josephine Tumuhamye; Hans Steinsland; Freddie Bwanga; James K Tumwine; Grace Ndeezi; David Mukunya; Olive Namugga; Agnes Napyo Kasede; Halvor Sommerfelt; Victoria Nankabirwa
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-17       Impact factor: 4.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.